For: | Vashist YK, Tiffon C, Stoupis C, Redaelli CA. Inhibition of hepatic tumor cell proliferation in vitro and tumor growth in vivo by taltobulin, a synthetic analogue of the tripeptide hemiasterlin. World J Gastroenterol 2006; 12(42): 6771-6778 [PMID: 17106924 DOI: 10.3748/wjg.v12.i42.6771] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v12/i42/6771.htm |
Number | Citing Articles |
1 |
Xiukun Lin, Lanhong Zheng. Bioactive Compounds from Marine Foods. 2013; : 73 doi: 10.1002/9781118412893.ch4
|
2 |
Boris A. Hadaschik, Hans Adomat, Ladan Fazli, Yves Fradet, Raymond J. Andersen, Martin E. Gleave, Alan I. So. Intravesical Chemotherapy of High-Grade Bladder Cancer with HTI-286, A Synthetic Analogue of the Marine Sponge Product Hemiasterlin. Clinical Cancer Research 2008; 14(5): 1510 doi: 10.1158/1078-0432.CCR-07-4475
|
3 |
Boris A. Hadaschik, Susan Ettinger, Richard D. Sowery, Amina Zoubeidi, Raymond J. Andersen, Michel Roberge, Martin E. Gleave. Targeting prostate cancer with HTI‐286, a synthetic analog of the marine sponge product hemiasterlin. International Journal of Cancer 2008; 122(10): 2368 doi: 10.1002/ijc.23406
|
4 |
Luciana Meli, Eric T. Jordan, Douglas S. Clark, Robert J. Linhardt, Jonathan S. Dordick. Influence of a three-dimensional, microarray environment on human Cell culture in drug screening systems. Biomaterials 2012; 33(35): 9087 doi: 10.1016/j.biomaterials.2012.08.065
|
5 |
Michael T. Davies-Coleman, Suthananda N. Sunassee. Drug Discovery in Africa. 2012; : 193 doi: 10.1007/978-3-642-28175-4_8
|